| Primary |
| Product Used For Unknown Indication |
43.0% |
| Drug Use For Unknown Indication |
12.6% |
| Epilepsy |
6.7% |
| Schizophrenia |
5.2% |
| Hypertension |
4.4% |
| Urinary Tract Infection |
3.7% |
| Anaemia Vitamin B12 Deficiency |
3.0% |
| Chemotherapy |
3.0% |
| Rheumatoid Arthritis |
3.0% |
| Homocystinuria |
2.2% |
| Abdominal Discomfort |
1.5% |
| Anaemia |
1.5% |
| Blood Homocysteine Increased |
1.5% |
| Folate Deficiency |
1.5% |
| Hyperemesis Gravidarum |
1.5% |
| Immunisation |
1.5% |
| Immunosuppression |
1.5% |
| Pregnancy |
1.5% |
| Anaemia Megaloblastic |
0.7% |
| Arthritis |
0.7% |
|
| Nausea |
12.1% |
| Anaphylactic Shock |
6.1% |
| Drug Exposure During Pregnancy |
6.1% |
| Drug Hypersensitivity |
6.1% |
| Exposure During Pregnancy |
6.1% |
| Foetal Exposure During Pregnancy |
6.1% |
| Hypersomnia |
6.1% |
| Palpitations |
6.1% |
| Urinary Tract Infection |
6.1% |
| Ventricular Septal Defect |
6.1% |
| Vomiting |
6.1% |
| Blood Alkaline Phosphatase Increased |
3.0% |
| Breast Cancer Female |
3.0% |
| Completed Suicide |
3.0% |
| Dementia |
3.0% |
| Dizziness |
3.0% |
| Drug Ineffective |
3.0% |
| Epilepsy |
3.0% |
| Fallot's Tetralogy |
3.0% |
| Gastroenteritis Viral |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
29.1% |
| Drug Use For Unknown Indication |
23.3% |
| Rheumatoid Arthritis |
11.0% |
| Drug Exposure During Pregnancy |
6.5% |
| Hypertension |
4.5% |
| Epilepsy |
3.3% |
| Pain |
2.5% |
| Foetal Exposure During Pregnancy |
2.3% |
| Prophylaxis |
2.3% |
| Ovarian Cancer |
1.8% |
| Schizophrenia |
1.8% |
| Urinary Tract Infection |
1.5% |
| Pregnancy |
1.5% |
| Psoriatic Arthropathy |
1.4% |
| Agitation |
1.4% |
| Colon Cancer |
1.4% |
| Hiv Infection |
1.4% |
| Depression |
1.1% |
| Anaemia |
1.0% |
| Non-hodgkin's Lymphoma |
1.0% |
|
| Vomiting |
9.6% |
| Drug Exposure During Pregnancy |
7.1% |
| Galactorrhoea |
6.8% |
| Premature Baby |
6.5% |
| Therapeutic Agent Toxicity |
6.5% |
| White Blood Cell Count Increased |
6.5% |
| Abnormal Dreams |
5.6% |
| Tumour Lysis Syndrome |
5.3% |
| Urinary Tract Infection |
5.0% |
| Ventricular Extrasystoles |
4.7% |
| Foetal Exposure During Pregnancy |
4.3% |
| Maternal Exposure During Pregnancy |
4.3% |
| Rash |
4.0% |
| Ventricular Septal Defect |
4.0% |
| Completed Suicide |
3.4% |
| Pyrexia |
3.4% |
| Urine Output Decreased |
3.4% |
| Constipation |
3.1% |
| Maternal Drugs Affecting Foetus |
3.1% |
| Pregnancy |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.8% |
| Rheumatoid Arthritis |
22.6% |
| Drug Use For Unknown Indication |
16.4% |
| Hypertension |
4.2% |
| Prophylaxis |
3.9% |
| Pain |
3.2% |
| Vitamin Supplementation |
2.9% |
| Crohn's Disease |
2.5% |
| Non-small Cell Lung Cancer |
2.2% |
| Psoriatic Arthropathy |
1.8% |
| Osteoporosis |
1.7% |
| Depression |
1.7% |
| Diabetes Mellitus |
1.3% |
| Supplementation Therapy |
1.2% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Blood Cholesterol Increased |
1.0% |
| Arthritis |
0.9% |
| Paroxysmal Nocturnal Haemoglobinuria |
0.9% |
| Anxiety |
0.9% |
| Psoriasis |
0.8% |
|
| Vomiting |
11.2% |
| Weight Decreased |
8.0% |
| Injection Site Pain |
7.6% |
| Pneumonia |
6.5% |
| Pyrexia |
5.8% |
| Rheumatoid Arthritis |
5.4% |
| Urinary Tract Infection |
5.3% |
| Pain |
5.0% |
| Death |
4.8% |
| Drug Ineffective |
4.4% |
| Weight Increased |
4.3% |
| Nausea |
4.1% |
| Rash |
4.0% |
| Sepsis |
3.8% |
| Thrombocytopenia |
3.8% |
| Pain In Extremity |
3.7% |
| Sinusitis |
3.4% |
| Myocardial Infarction |
3.2% |
| Headache |
3.0% |
| Dyspnoea |
2.9% |
|
| Interacting |
| Drug Use For Unknown Indication |
39.3% |
| Product Used For Unknown Indication |
31.4% |
| Drug Exposure During Pregnancy |
5.7% |
| Convulsion |
2.9% |
| Grand Mal Convulsion |
2.9% |
| Prophylaxis |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Atrial Fibrillation |
2.1% |
| Epilepsy |
2.1% |
| Hepatitis C |
2.1% |
| Anaemia Of Malignant Disease |
1.4% |
| Vitamin Supplementation |
1.4% |
| Inflammation |
0.7% |
| Lyme Disease |
0.7% |
| Non-small Cell Lung Cancer |
0.7% |
| Pain |
0.7% |
|
| Rash |
16.7% |
| Neural Tube Defect |
13.3% |
| Prescribed Overdose |
10.0% |
| Vomiting |
10.0% |
| Epilepsy |
6.7% |
| Diarrhoea |
3.3% |
| Drug Ineffective |
3.3% |
| Drug Interaction |
3.3% |
| Feeling Abnormal |
3.3% |
| Haemorrhoidal Haemorrhage |
3.3% |
| Humerus Fracture |
3.3% |
| Malignant Neoplasm Progression |
3.3% |
| Nasal Disorder |
3.3% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
3.3% |
| Rotator Cuff Syndrome |
3.3% |
| Tooth Injury |
3.3% |
| Visual Impairment |
3.3% |
| Vitamin D Deficiency |
3.3% |
|
